Evidence suggests that alterations of glucose and lipid homeostasis induced by obesity are associated with elevation of endocannabinoid tone. The biosynthesis of the two main endocannabinoids, N-arachidonoyl-ethanolamine (AEA) and 2-arachidonoyl-glycerol (2-AG), which derive from arachidonic acid, is influenced by dietary fatty acids (FA).
INTRODUCTION
The endocannabinoid system (ECS) is known to play a crucial role in energy homeostasis. Regulation by this system takes place at the central level by changing food intake (1) and at the peripheral level by modification of energy metabolism (2) . An overactive ECS plays a crucial role in obesity by increasing food intake (3) and lipogenesis (4) , by down-regulating catabolic reactions (5; 6); and promoting fat accumulation and alteration of glucose homeostasis. As a consequence, treating obesity by decreasing ECS activity has been considered. A pharmacological approach was developed, leading to the commercialization of an inverse agonist of the cannabinoid receptor type-1 (CB1R), Rimonabant. However, this drug was withdrawn from the market due to its undesired central nervous system side effects (7) . Meanwhile, down-regulation of ECS tone in peripheral tissues involved in energy homeostasis, either with non-brain penetrant CB1R blockers, or inhibitors of the biosynthesis of endogenous CB1R agonists, is still considered as a potential approach to counter the adverse events observed in obesity (8) .
The ECS is defined as a set of endogenous ligands (endocannabinoids; EC), synthesized and degraded by specific enzymes and receptors able to bind these molecules. It includes two membrane receptors, CB1R and CB2R, and two main endogenous agonists, Narachidonoyl-ethanolamine (anandamide or AEA) and 2-arachidonoyl-glycerol (2-AG). AEA is typically synthesized by the enzyme N-acylphosphatidylethanolamine phospholipase D (NAPE-PLD), although alternative pathways exist, while 2-AG is formed by the action of diacylglycerol lipase α or β upon diacylglycerols. After release, EC are subjected to rapid breakdown by degrading enzymes such as fatty acid amide hydrolase (FAAH) for Nacylethanolamines and monoacylglycerol lipase (MAGL) for 2-AG (9) ( Figure 1A ).
AEA and 2-AG are lipids and both ultimately derive from arachidonic acid (AA, C20:4n-6) via AA-containing phospholipids. AA is endogenously biosynthesized from the essential fatty acid (10) linoleic acid (LA, C18:2n-6). As a consequence, a dietary supplementation in LA (11; 12) or AA itself (13) is able to elevate tissue contents of EC.
Conversely, diets enriched with n-3 polyunsaturated fatty acids (PUFA), such as eicosapentaenoic acid (EPA; C20:5n-3) and docosahexaenoic acid (DHA, C22:6n-3), cause a decrease in 2-AG and AEA levels because of the replacement of AA in phospholipids with such FA (13; 14) .
It is well known that dietary n-3 FA exert beneficial effects on obesity (15) . For instance, n-3 FA have the ability to reduce ectopic fat and inflammation in Zucker rats and to reduce glucose intolerance generally associated with obesity (16) . Thus, they were shown to improve insulin sensitivity and gluconeogenesis in rodents (17, 18) . The existence of a direct causal link between EC tone and the ability of n-3 FA to improve some of these features of obesity has been recently evidenced (16) , involving transcription factors such as CREBH (19) and SREBP (20) . This emphasizes the potential benefits of nutritional interventions in the treatment of pathologies related to obesity, particularly using n-3 FA.
Accumulating evidence shows that dietary factors, including lipids, in developmental periods such as fetal life, infancy, and early childhood, are associated with obesity risk later in life (21) . In line with this, it has been shown that early overnutrition leads to persistent dysregulation in leptin and insulin sensitivity (22) , along with enhanced inflammatory response (23) . In addition to excess calories, the FA composition of the perinatal diet is also an important factor in the nutritional programming of the metabolic phenotype in adulthood.
Recent studies have shown that perinatal exposure to a rich n-6 FA diet is able to induce obesity and to affect body fat mass across generations (24) . On the other hand, the beneficial role of dietary n-3 FA during early life has been emphasized since n-3 FA deficiency increases adiposity in guinea pigs (25) . This idea was reinforced by the study of Masseria et al. showing that addition of α-linolenic acid (α-LNA, C18:3n-3) to a LA rich high-fat diet (HFD) under isolipidic and isocaloric conditions, reduces the deleterious effect of n-6 FA when given to mouse pups (26) . The beneficial preventive effect of n-3 FA is not restricted to HFD. Even in a normolipidic diet, they are able to limit HFD-induced insulin resistance and hepatic steatosis, two main features of obesity (27) . In keeping with this, improvement of glucose and lipid homeostasis was also observed in transgenic Fat-1 mice, which can synthesize n-3 FA from n-6 FA without the need for dietary supplementation (28) .
In this study, we aimed to investigate the role of the FA composition of a normolipidic diet (n-6 vs n-3 FA) in the early prevention of HFD-induced obesity and its relationship with the EC tone. Our starting hypothesis was that a n-3 FA enriched diet given to weaning mice can decrease ECS activity, which in turn prevents HFD-induced metabolic disorders. To support our data, we also examined liver EC tone in Fat-1 mice presenting consistently high levels of n-3 FA in their tissues.
RESEARCH DESIGN AND METHODS

Animals and diets
Official French regulations (n°87848) for the use and care of laboratory animals were followed throughout the experimental period. The experimental protocol was approved by the local ethic committee for animal experimentation (n°BX0622). Three week-old C57BL/6J male mice were purchased from Charles River Laboratories (France). Mice surviving to the stress of delivery were randomly separated in 3 series of 14-16 animals receiving different low fat diets (LFD; 5% wt/wt total lipids) for 10 weeks as schematized in Figure 1B . Animals were housed individually on a 12h/12h light/dark schedule at 22-23°C with ad libitum access to water and food. Lipids in Lard series came exclusively from pork fat while lard was partially substituted with safflower oil or linseed oil in SAF and LIN series respectively. The FA composition of the custom diets manufactured by SSNIF (Soest, Germany) is presented in Table 1 . After 10 weeks, half of the population of each series was used for analyses and the rest was challenged with a high fat diet (HFD; 30% wt/wt total lipids from lard) for an additional period of 10 weeks. C57BL/6J transgenic fat-1 mice were generated and housed as described previously (29) .
Body and plasma parameters
Body composition (fat mass, lean mass, and total body water) was measured by EchoMRI (Echo Medical Systems; Houston, TX). Plasma triglyceride (TG) and cholesterol (CS) concentrations were determined using commercial kits (Dyasis, France). Adiponectin levels were measured by enzyme-linked immunosorbent assay (ELISA) from Merck Millipore (Darmstadt, Germany) while leptin and insulin plasma content was determined using a luminex®-based Bio-Rad® Bio-Plex Pro™ mouse assay (Bio-Rad, Marnes-La-Coquette France).
Glucose tolerance and insulin tolerance tests
For oral glucose tolerance test (OGTT) and insulin tolerance test (ITT), mice respectively received an oral load (2g/kg) of a D-glucose solution (20% w/v) or an intraperitoneal injection of insulin (0.5 UI/kg; Actrapid®, Novo Nordisk, France) after a 6-hour fasting. OGTT and ITT were performed on the same mice within a 3-day interval. Glycemia was measured at 0, 
Lipid and EC analyses
For determination of total FA composition in tissues and diets, lipids were extracted according to Folch et al. (30) . Concentrations were determined using C17:0 as internal standard, after methylation according to the procedure of Christie (31) and separation by gas chromatography (GC) as previously described (32) . EC and congeners were purified from lipid extracts and determined by isotope dilution liquid chromatography-atmospheric pressure chemical ionization-mass spectrometry (LC-MS) using deuterated standards as described in (33) .
Western blots analysis
The isolation and quantification of total proteins from tissues was performed as previously described (34 
Enzyme assays
FAAH and MAGL activity was measured as previously described (34) . In particular, 2-AG hydrolysis was measured by incubating the 10.000 x g liver cytosolic fraction (100 µg/sample) in Tris-HCl 50 mM, at pH 7.0 at 37 °C for 20 min, with synthetic 2-arachidonoyl- .
RT-PCR
Total mRNAs from tissues were extracted with Tri-Reagent (Euromedex, Souffelweyersheim, France) and 1 µg RNA was reverse-transcripted using the Iscript cDNA kit (Bio-Rad). Real-time PCR was performed as described previously (6) 
Statistical analysis
Results are expressed as means ± SEM. Data were analyzed statistically using 2-way ANOVA followed by the Tukey post-hoc test, or using Student t-test. Differences were considered significant at P<0.05.
RESULTS
Liver total FA composition
Lard used for the preparation of the LFD was partially replaced by safflower oil (SAF) or linseed oil (LIN) to modify the proportions of LA and α-LNA while limiting background variations. In this way, the final n-6/n-3 FA ratios in Lard, SAF and LIN diets were 22, 53 and 1 respectively ( Table 1 ). The impact of 10 weeks feeding with the different LFD was estimated through the analysis of total liver FA composition ( Table 1) . As expected, when compared to Lard, SAF diet increased proportions of LA and AA in liver lipids at the expense of C18:1n-9, while LIN induced an increase in DHA. This resulted in strong alterations of tissue n-6/n-3 FA ratios. After challenging the animals with a 30% lard oil diet for 10 weeks, the liver SAF and LIN FA profiles became very close to that of the Lard diet. Nevertheless, the n-6/n-3 FA ratio in liver LIN remained slightly lower than Lard and SAF.
Tissue EC levels
Switching n-6/n-3 FA ratio from 53 to 1 in the diet (SAF vs LIN) affected both AEA and 2-AG tissue levels in the liver ( Figure 2 ). Comparing SAF vs Lard group aimed to reflect the impact of a specific elevation of LA on tissue EC contents. Elevating dietary LA increased only 2-AG in the liver. Likewise, the specific impact of the elevation of n-3 FA in the diet on EC levels was estimated by comparing LIN to Lard group. In these conditions, AEA was significantly lower in the liver of LIN mice compared with Lard while the same trend was observed for 2-AG. In other tested tissues (supplemental figure 1), huge nutritional alteration of n-6/n-3 FA ratio in the diet always significantly reduced AEA levels except for visceral adipose tissue (VAT). 2-AG was concomitantly reduced in brain and muscle but not modified in subcutaneous adipose tissue (SCAT) nor VAT.
Whatever the early diet administered, feeding the HFD raised liver AEA and 2-AG levels ( Figure 2 ). However, the increase was not significant for 2-AG in SAF series since levels were already elevated at the end of the LFD. EC levels were also generally increased after the HFD in brain, VAT and muscle. Otherwise, SCAT appeared to be differently influenced by the HFD regardless of the early diet as suggested by the decrease in EC levels (supplemental figure 1).
Transcriptomic and proteomic analysis of ECS (Figure 3A-C)
Data concerning FAAH and MAGL, which mainly hydrolyze AEA and 2-AG respectively, indicated that the liver protein levels and activity of MAGL were more influenced by the composition of the early diet than FAAH. In particular, both MAGL protein levels and activity were reduced by SAF compared to other diets in accordance with higher levels of 2-AG in this group. Protein levels of NAPE-PLD, which is involved in the formation of AEA, were also reduced by SAF and LIN compared to Lard diet. Regarding CB1R, liver mRNA levels were unchanged whatever the diet.
Challenging mice with 30% lard diet induced more pronounced alteration of liver enzymes linked to ECS. Data related to FAAH indicated a strong downregulation while NAPE-PLD was increased suggesting an inverse regulation of EC degradation and biosynthetic pathways in favor of an elevation of AEA levels. HFD concomitantly induced the mRNA expression of CB1R in the liver for all groups. Interestingly, the impact of the HFD sometimes appeared to depend on the nutritional history. In particular, CB1R mRNA expression was lower in the LIN compared to SAF group and FAAH protein levels were higher in the LIN than in Lard group.
Body composition, plasma parameters and glycemic control
Body weight and fat pad relative mass measured at the end of the early LFD did not differ among the three groups (Table 2) . Nevertheless, LIN induced a significant decrease in total fat mass as determined by echoMRI. The particular sensitivity of the liver to the different early diets was indicated by the decrease in relative mass and lipid content induced by SAF and LIN compared to Lard. Similarly, muscle lipids were also the highest for the Lard group (data not shown). As expected, total body fat, fat pad weight and tissue lipids were increased after the HFD challenge but no differences were observed between groups.
Early feeding with SAF and LIN experimental diets improved some important plasma parameters related to glucose and lipid homeostasis in comparison with Lard (Table 2) .
Notably, fasting triglyceridemia and cholesterolemia were reduced after SAF and LIN diets.
While these diets did not affect glycemia, insulin levels in these groups were higher than in
Lard suggesting a possible impairment of beta-cell function by early and prolonged exposure to Lard diet. Interestingly, plasma adiponectin was significantly higher in LIN than in Lard pointing out a putative impact of n-3 FA on adipose tissue metabolism. Data relative to glycemic control ( Figure 4A and B) showed that only the LIN diet exerted slight changes on glucose clearance after oral glucose load or insulin administration.
As expected, HFD challenge induced marked variations in most of the metabolic parameters measured (Table 2) . Glycemia, cholesterolemia, insulinemia, adiponectin and leptin increased in all groups. The slight hyperglycemia associated to the compensatory hyperinsulinemia reflected the onset of an insulin resistant state whatever the early diet consumed. However calculations derived from OGTT and insulin response (DI 0-15 /DG 0-15 and DI 0 ) suggested an alteration in beta-cell function for mice fed with the Lard diet only ( Table   2 ). Data also revealed that animals fed with the diet enriched in n-3 FA during 10 weeks following weaning had higher plasma adiponectin levels and better glycemic control after HFD challenge. Notably, OGTT, ITT and HOMA-IR were improved in the LIN group compared to the others ( Figure 4C and D and Table 2 ). In addition, t 0-30min insulin production in response to glucose load was also significantly higher in LIN than Lard ( Figure 4E ).
Expression of genes related to carbohydrate and lipid metabolism in the liver (Figure 5)
The fact that early feeding with LIN induced long-lasting positive effects on glycemic control prompted us to study the impact of the different diets on the expression of genes related to carbohydrate and lipid metabolism in the liver. Thus, early feeding with the LIN diet significantly decreased mRNA levels of the key gluconeogenic enzymes genes PEPCK and G6P as well as that of GK, FAS, SCD1 and the transcription factor CREBH compared with the Lard group. Data also revealed that young mice fed with the diet containing exclusively lard as lipid source showed the highest mRNA expression of FAT/CD36 and LPL genes related to FA uptake. This observation also applied to TNFα mRNA levels suggesting an elevated liver inflammatory status in Lard mice liver which was decreased by the SAF and LIN diets.
Whatever the early diet, feeding mice with HFD induced changes in the expression of genes responsive to insulin such as PEPCK and GK, which were respectively decreased and increased. We further noticed that mice prefed with the LIN diet showed lower expression of several genes after HFD challenge compared with other diets suggesting that addition of n-3
FA in the early diet may induce biological imprinting mechanisms controlling gene expression. In this way, PEPCK, CREBH, LPL, and TNFα mRNA levels were lower in LIN than SAF and Lard groups.
EC levels and gene expression in Fat-1 mice liver (Figure 6)
For further insight on the impact of n-3 FA tissue enrichment on ECS tone, we measured EC content in the liver of Fat-1 mice. These transgenic animals are able to endogenously synthesize n-3 FA from n-6 FA and consequently exhibit high levels of n-3 FA in their tissues. Interestingly, EC levels were strongly reduced in Fat-1 mouse livers ( Figure 6A ). We also found that the expression of FAAH, PEPCK, G6P and FAS gene was lower in Fat-1 than in wild type mice ( Figure 6B ).
DISCUSSION
The objective of this study was twofold. First, we explored whether early exposure to a diet enriched in n-3 or n-6 FA could concomitantly influence EC tone in several mouse tissues and metabolic parameters with particular attention to the liver, considered the most vulnerable organ following nutritional programming during perinatal period. Secondly, we examined the long-term effects of these postnatal nutritional manipulations by examining whether they were associated with alterations of metabolic parameters in response to a later HFD challenge. Our data indicate in particular that exposure to an n-3 FA-enriched diet in the early age induces a marked reduction in liver ECS activity associated with an alteration of key enzymes involved in liver carbohydrate and lipid metabolism. In addition, we observed that some of the liver gene expression modifications induced by n-3 FA feeding in the first weeks of life persisted after HFD challenge and were associated with an improved glycemic control.
A recent series of studies carried out by Alvheim et al. highlighted the importance of the dietary LA on EC tone (11; 12; 14) . These works demonstrated that excessive LA consumption elevates tissue EC levels and is associated with metabolic alterations. Here, some important issues concerning the impact of dietary FA, and particularly n-3 FA, on ECS activity were also emphasized. First, we observed that the substitution of 0.5% Lard for LIN in the early diet was sufficient to decrease EC levels in brain, liver and muscle. Since EC tissue levels were generally decreased when the diet was enriched in α-LNA regardless of changes in LA levels, it might be suggested that EC synthesis is more influenced by n-3 than n-6 dietary FA. The fact that increasing LA in the diet while α-LNA levels remained constant did not induce marked variation in EC levels also supports this assumption. In line with this, the decrease in liver AEA induced by chronic administration of LIN compared to Lard could not be due to a net decrease in the supply of n-6 biosynthetic precursors of EC since LA levels were in the same range in the two diets. Instead, competition between n-6 and n-3 FA for elongation and desaturation steps may be crucial for EC synthesis in these conditions. We also found here that early dietary n-3 FA reduces EC levels in the brain and the skeletal muscle. Decreases in both AEA and 2-AG, with the former persisting after HFD challenge, were observed in the LIN compared to SAF group. In the whole, these findings, in agreement with previous data in adult mice (35) and rats (34) (36), confirm that early dietary interventions based on n-3 FA, might constitute an alternative strategy to "global" CB1R blockers to reduce ECS overactivity, and subsequently, various parameters of the metabolic syndrome, while possibly limiting the consequences on brain function.
Animals from the Lard series were fed with a 5% lipid diet consisting mainly of long chain saturated and monounsaturated FA initially prone to induce metabolic disorders related to insulin resistance. So it was not surprising to observe that replacing part of the Lard with SAF or LIN in the diet was able to limit the alterations of some metabolic parameters such as triglyceridemia, cholesterolemia, and liver and muscle lipid content in agreement with previous studies (37) . The lower insulin levels observed in Lard compared to SAF and LIN mice may also represent an impairment of beta-cell function induced by prolonged exposure to saturated FA (38) . However, a notable finding from this work is that only the diet enriched with α-LNA induced specific changes in the liver expression of genes involved in gluconeogenesis and de novo lipogenesis. Thus, LIN diet decreased PEPCK, G6P and GK mRNA levels suggesting a slowing down of liver glucose production. Molecular data also Our findings are reminiscent of those observed in Fat-1 transgenic mice, which can endogenously synthesize n-3 FA from n-6 FA and consequently show elevated levels of DHA in the liver compared to wild type mice. They also appear to be protected from HFD-induced glucose intolerance, dyslipidemia and liver steatosis (10; 41) . A recent study indicated that
Fat-1 mice display reduced capacity for gluconeogenesis and lipid synthesis as suggested by the low hepatic protein expression of PEPCK, G6P, ACC and FAS in the liver (28) .
Interestingly, whilst confirming lower mRNA levels of these enzymes, we demonstrated that AEA and 2-AG levels are also strongly reduced in the liver of Fat-1 mice.
The observation that tissue enrichment with n-3 FA (by dietary or transgenic manipulation) induces a significant decrease in ECS tone in the liver and muscle supports the possible existence of a direct causal link between the decrease in EC tone induced by LIN diet and the improvement of metabolic parameters observed in our study. The role of the ECS in regulating glucose homeostasis is well known (19; 42-44) . In particular, studies using liverspecific CB1R knockout mice demonstrated that hepatic CB1R activation is both necessary and sufficient to account for diet-induced hepatic insulin resistance (42) . In primary hepatocytes, direct CB1R activation was found to induce glucose production by increasing expression of CREBH and gluconeogenic genes (19) . CREBH is a liver-specific transcription factor recently described as a crucial actor in the regulation of hepatic glucose metabolism in mammals. CREBH has been shown to be induced by fasting or insulin-resistant state in rodents and to activate transcription of PEPCK or G6Pase gene. Consistent with this, we observed that mice fed with the LIN diet show low levels of PEPCK, G6P and CREBH associated with a reduced activity of the ECS in the liver. Therefore, it is conceivable that the low gluconeogenic gene expression observed in the liver of these mice is mediated by reduced CREBH expression observed in response to the decrease in EC tone induced by n-3 FA exposure. It is widely accepted that the nutritional environment and weight gain in the first years of life are associated with the risk of developing metabolic disorders. It has been shown that during the postnatal period, a metabolic imprinting may occur and predispose to an early onset and aggravation of metabolic disorders induced by exposure to HFD later in life (46) . In the current study, the impact of early diets on the susceptibility to develop metabolic disorders induced by a subsequent HFD was tested challenging mice with a 30% lard-based diet for 10
weeks. Evidence has accumulated indicating a tonic overactivation of ECS following HFDinduced obesity (14; 35; 47) . Nevertheless, data from the literature also suggest that the effect of HFD feeding on peripheral EC levels may depend on the FA composition of the diet (12; 14; 48) . In the present study, we consistently observed that tissue EC contents were generally higher after chronic administration of the HFD, whatever the early LFD. Liver transcriptomic and proteomic analyses related to the ECS also supported a stimulatory effect of HFD on EC tone as indicated by the marked increase in NAPE-PLD and CB1R expression along with the concomitant decrease in FAAH expression and activity. However an important finding concerns EC levels in the inguinal AT, which were lowered in all groups after HFD challenge in agreement with previous works concerning the impact of HFD on adipose depots of both rodents and humans (47; 49) . Since leptin and insulin were strongly increased after HFD challenge, it might be suggested that the decrease in SCAT EC levels is due to the action of these hormones on EC production as previously shown (50; 51). This possibility implies that our dietary conditions did not yet alter SCAT metabolism to such a degree that it became resistant to hormonal control. The fact that adiponectin levels were increased by HFD suggests that fat depots still had the capacity to expand by recruiting new adipocytes. Indeed, adiponectin production is suppressed as adipocytes become hypertrophic and macrophages infiltrate the tissue (52). So, it would be informative to determine whether ECS activity is still decreased in other more severe models of obesity in which the SCAT shows excessive hypertrophy and metabolic stress.
Feeding mice with 30% lard caused the typical metabolic disorders due to diet-induced obesity independently on the postnatal nutritional history. However the metabolic consequences were somehow limited likely due to the total lipid content and the duration of the diet, which were not elevated. Thus, mice became fatter, showed liver triglyceride accumulation, hyperinsulinemia, hyperleptinemia, slight hyperglycemia and hypercholesterolemia. While the differences concerning liver EC tone and lipid composition induced by the LIN early diet did not persist after HFD challenge, we interestingly observed a better glucose tolerance in these animals compared with the Lard and SAF groups. Data further suggest that the better glycemic control observed in mice fed with the early LIN diet was not dependent on beta cell function but rather associated with an improvement of insulin sensitivity. This may be closely related to the reduced expression of some key genes involved in lipid and carbohydrate homeostasis in the liver of LIN fed mice. Although differences were not always quite statistically significant for genes taken individually, the concomitant decrease in CB1R, PEPCK, G6P, CREBH, FAS, SCD1, SREBP1c, FAT/CD36, LPL and TNFα mRNA levels collectively suggests the existence of a metabolic imprinting set up by the early n-3 FA exposure period.
In conclusion our results strongly support the possibility that early dietary n-3 FA induce a decrease in liver EC tone giving rise to modifications persisting later in life and promoting resistance towards metabolic complications induced by an obesogenic diet. These findings support the emerging notion that dietary n-3 FA could be an alternative strategy to drug use to reduce overactivity of peripheral ECS, and consequently improve or prevent metabolic disorders related to obesity. Then mice were all challenged with a 30% lard diet for 10 additional weeks (HF diet challenge). Results are expressed as means ± SEM (n=3-6). Two different superscript letters indicate significant statistical differences between groups after early LF diet or after HF diet challenge at p<0.05. *Asterisks indicate significant statistical differences between HF diet challenge vs corresponding early LF diet means (p<0.05). Liver fatty acids (FA) are expressed as means ± SEM (n=7-9). Two different superscript letters indicate significant statistical differences between groups after early LF diet or after HF diet challenge at p<0.05. Values are not indicated when fatty acid content did not reach 1g/100g in at least one series. *Asterisks indicate significant statistical differences between HF diet challenge vs corresponding early LF diet means (p<0.05). All parameters except glucose levels were measured from blood and tissue samples collected the day of sacrifice on overnight-fasted animals. Glucose levels and calculations were determined from blood samples collected during OGTT experiments initiated with 6h-fasting animals.
HOMA-IR = fasting glucose (mmol/l)*fasting insulin(µUI/l)/22.5. DI 0-15 /DG 0-15 : insulin production to glucose load (µUI/mmol). DI 0 : Oral disposition index (mmol -1 ) = (DI 0-15 /DG 0-15 )*1/fasting insulin Results are expressed as means ± SEM (n=7-9). Two different superscript letters indicate significant statistical differences between groups after early LF diet or after HF diet challenge at p<0.05. *Asterisks indicate significant statistical differences between HF diet challenge vs corresponding early LF diet means (p<0.05).
